Spicing up the military: Use and effects of synthetic cannabis in substance abusing army personnel

Addictive Behaviors

Volumn 39, Issue 7, 2014, Pages 1139-1144

  Walker, Denise ^a   Neighbors, Clayton ^b   Walton, Thomas ^a   Pierce, Adam ^a   Mbilinyi, Lyungai ^a   Kaysen, Debra ^a   Roffman, Roger ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Army; Military; Spice; Substance abuse; Synthetic cannabis

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABIS; ILLICIT DRUG; METHAMPHETAMINE; OPIATE; SEDATIVE AGENT; SYNTHETIC CANNABIS; UNCLASSIFIED DRUG; STREET DRUG;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; DEPRESSION; DSM-IV; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POSTTRAUMATIC STRESS DISORDER; SOLDIER; SUBSTANCE ABUSE; SUBSTANCE USE; EPIDEMIOLOGY; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

FEMALE; HUMANS; MALE; MILITARY PERSONNEL; NORTHWESTERN UNITED STATES; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84898622176     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2014.02.018     Document Type: Article

References (48)

1. (IOM) Institute of Medicine Substance use disorders in the US armed forces 2012, The National Academies Press, Washington, DC.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorder: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC.
3. Army Substance Abuse Program Expansion of synthetic cannabinoids to military urinalysis testing (ALARACT 310/2013) Retrieved from, (on 1/19/14). http://acsap.army.mil/Pdf/ALARACT%20310-2013.pdf.
4. Auwärter V., Dresen S., Weinmann W., Müller M., Pütz M., Ferreiros N. 'Spice' and other herbal blends: Harmless incense or cannabinoid designer drugs?. Journal of Mass Spectrometry 2009, 44(5):832-837. 10.1002/jms.1558.
5. Baer J.S., Stacy A., Larimer E.M. Biases in the perception of drinking norms among college students. Journal of Studies on Alcohol 1991, 52:580-586.
6. Bebarta V.S., Ramirez S., Varney S.M. Spice: A new "legal" herbal mixture abused by young active duty military personnel. Substance Abuse 2012, 33:191-194. 10.1080/08897077.2011.637610.
7. Blanchard E.B., Jones-Alexander J., Buckley T.C., Forneris C.A. Psychometric properties of the PTSD checklist (PCL). Behaviour Research and Therapy 1996, 34(8):669-673. 10.1016/0005-7967(96)00033-2.
8. Brown S.A., Myers M.G., Lippke L., Tapert S.F., Stewart D.G., Vik P.W. Psychometric evaluation of the Customary Drinking and Drug Use Record (CDDR): A measure of adolescent alcohol and drug involvement. Journal of Studies on Alcohol 1998, 59(4):427-438.
9. Castellanos D., Singh S., Thornton G., Avila M., Moreno A. Synthetic cannabinoid use: A case series of adolescents. Journal of Adolescent Health 2011, 49(4):347-349. 10.1016/j.jadohealth.2011.08.002.
10. Daugherty R., O'Bryan T. Prime for life participant workbook version 8.0 2004, Prevention Research Institute, Lexington, KY.
11. Department of Defense (DOD) Prohibited substances (Spice in variations). Secretary of the Army 2011, February 10, John McHugh, Washington, DC, (Retrieved from: http://ascap.army.mil/Pdf/Sec_ArmyProhibited_Substances-Spice_in_Variations)-Memo.pdf).
12. Every-Palmer S. Warning: Legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction 2010, 105:1859-1861. 10.1111/j.1360-0443.2010.03119.x.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV) 1997, American Psychiatric Press, Inc., Washington, D.C.
14. Forcehimes A.A., Tonigan J.S., Miller W.R., Kenna G.A., Baer J.S. Psychometrics of the drinker inventory of consequences (DrInC). Addictive Behaviors 2007, 32(8):1699-1704. 10.1016/j.addbeh.2006.11.009.
15. Forrester M.B., Kleinschmidt K., Schwarz E., Young A. Synthetic cannabinoid exposures reported to Texas poison centers. Journal of Addictive Diseases 2011, 30(4):351-358. 10.1080/10550887.2011.609807.
16. Gunderson E.W., Haughey H.M., Ait-Daoud N., Joshi A.S., Hart C.L. "Spice" and "K2" herbal highs: A case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions 2012, 00:1-7. 10.1111/j.1521-0391.2012.00240.x.
17. Harris C.R., Brown A. Synthetic cannabinoid intoxication: A case series and review. The Journal of Emergency Medicine 2013, 44(2):360-366. 10.1016/j.jemermed.2012.07.061.
18. Hu X., Primack B.A., Barnett T.E., Cook R.L. College students and use of K2: An emerging drug of abuse in young persons. Substance Abuse Treatment, Prevention, and Policy 2011, 6(16):1-4. 10.1186/1747-597X-6-16.
19. Hughes B., Winstock A.R. Controlling new drugs under marketing regulations. Addiction 2012, 107(11):1894-1899. 10.1111/j.1360-0443.2011.03620.x.
20. Hurst D., Loeffler G., McLay R. Psychosis associated with synthetic cannabinoid agonists: A case series. American Journal of Psychiatry 2011, 168(10):1119. 10.1176/appi.ajp.2011.11060869r.
21. Jinwala F.N., Gupta M. Synthetic cannabis and respiratory depression. Journal of Child and Adolescent Psychopharmacology 2012, 22(6):459-462. 10.1089/cap.2011.0122.
22. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the future national survey results on drug use, 1975-2012: Volume 2, college students and adults ages 19-50 2013, Institute for Social Research, The University of Michigan, Ann Arbor.
23. Kau G. Flashback to the federal analog act of 1986: Mixing rules and standards in the cauldron. University of Pennsylvania Law Review 2008, 156:1077-1115.
24. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9. Journal of General Internal Medicine 2001, 16(9):606-613.
25. Kroenke K., Spitzer R.L., Williams J.B., Monahan P.O., Lowe B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Annals of Internal Medicine 2007, 146(5):317-325. 10.7326/0003-4819-146-5-200703060-00004.
26. Miller B.L., Boman J.H., Stogner J. Examining the measurement of novel drug perceptions: Salvia divinorum, gender, and peer substance use. Substance Use and Misuse 2013, 48:65-72.
27. Neighbors C., Dillard A.J., Lewis M.A., Bergstrom R.L., Neil T.A. Normative misperceptions and temporal precedence of perceived norms and drinking. Journal of Studies on Alcohol 2006, 67(2):290-299.
28. Neighbors C., Larimer M.E., Lewis M.A. Targeting misperceptions of descriptive drinking norms: Efficacy of a computer-delivered personalized normative feedback intervention. Journal of Consulting and Clinical Psychology 2004, 72:434-447. 10.1037/0022-006X.72.3.434.
29. Pemberton M.R., Williams J., Herman-Stahl M., Calvin S.L., Bradshaw M.R., Bray R.M., et al. Evaluation of two web-based alcohol interventions in the US military. Journal of Studies on Alcohol and Drugs 2011, 72:480-489.
30. Perkins H.W., Linkenbach J.W., Lewis M.A., Neighbors C. Effectiveness of social norms media marketing in reducing drinking and driving: A statewide campaign. Addictive Behaviors 2010, 35:866-874. 10.1016/j.addbeh.2010.05.004.
31. Perrone D., Helgesen R.D., Fischer R.G. United States drug prohibition and legal highs: How drug testing may lead cannabis users to Spice. Drugs: Education, Prevention and Policy 2013, 20(3):216-224. 10.3109/09687637.2012.749392.
32. Schifano F., Corazza O., Deluca P., Davey Z., Di Furia L., Farre' M., et al. Psychoactive drug or mystical incense? Overview of the online available information on Spice products. International Journal of Culture and Mental Health 2009, 2(2):137-144. 10.1080/17542860903350888.
33. Schneir A.B., Baumcacher T. Convulsions associated with the use of a synthetic cannabinoid product. Journal of Medical Toxicology 2012, 8(1):62-64. 10.1007/s13181-011-0182-2.
34. Schneir A.B., Cullen J., Ly B.T. Spice girls: Synthetic cannabinoid intoxication. Journal of Emergency Medicine 2011, 40:296-299. 10.1016/j.jemermed.2010.10.014.
35. Seely K.A., Lapoint J., Moran J.H., Fattore L. Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Ppsychopharmacology & Biological Psychiatry 2012, 39:234-243. 10.1016/j.pnpbp.2012.04.017.
36. Simmons J., Cookman L., Kang C., Skinner C. Three cases of "spice" exposure. Clinical Toxicology 2011, 49:431-433. 10.3109/15563650.2011.584316.
37. Simmons J.R., Skinner C.G., Williams J., Kang C.S., Schwartz M.D., Wills B.K. Intoxication from smoking "Spice". Annals of Emergency Medicine 2011, 57(2):187-188. 10.1016/j.annemergmed.2010.08.039.
38. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine 2006, 166(10):1092-1097.
39. Stephens J.L. Synthetic cannabinoid usage among college students: The example of K2 and spice 2011, 1511461. ((Master's thesis). Retrieved from ProQuest UMI dissertation publishing).
40. Stogner J.M., Miller B.L. A spicy kind of high: A profile of synthetic cannabinoid users. Journal of Substance Use 2013, 1-7. (early online). 10.3109/14659891.2013.770571.
41. Swinson R.P. The GAD-7 scale was accurate for diagnosing generalized anxiety disorder. Evidence Based Medicine 2006, 11:184. 10.1016/j.psychres.2011.01.016.
42. Vardakou I., Pistos C., Spiliopoulou C. Spice drugs as a new trend: Mode of action, identification and legislation. Toxicology Letters 2010, 197(3):157-162. 10.1016/j.toxlet.2010.06.002.
43. Walker D.D., Roffman R.A., Picciano J.F., Stephens R.S. The check-up: In-person, computerized, and telephone adaptations of motivational enhancement treatment to elicit voluntary participation by the contemplator. Substance Abuse Treatment, Prevention, and Policy 2007, 2(1):2-12. 10.1186/1747-597X-2-2.
44. Walton T.O., Walker D.D., Kaysen D.L., Roffman R.A., Mbilinyi L., Neighbors C. Reaching soldiers with untreated substance use disorder: Lessons learned in the development of a marketing campaign for the warrior check-up study. Substance Use and Misuse 2013, 43:908-921. 10.3109/10826084.2013.797996.
45. Washington State Department of Health Synthetic marijuana products to be banned in state under emergency rules: Board of pharmacy action follows federal ban [press release] Retrieved from. http://www.doh.wa.gov/Portals/1/Documents/1500/NewsReleases/2010/10-210PharmacyBoardK2-Spice-REVISED.pdf.
46. Weathers F.W., Litz B.T., Herman D.S., Keane T.M., Steinberg H.R., Huska J.A., et al. The PTSD checklist (PCL): Reliability, validity, and diagnostic utility. Paper presented at the annual meeting of the International Society for Traumatic Stress Studies, San Antonio, TX 1993, October.
47. Weathers F.W., Litz B.T., Huska J.A., Keane T.M. PTSD checklist - Civilian version 1994, National Center for PTSD, Behavioral Science Division, Boston.
48. Williams J., Herman-Stahl M., Calvin S.L., Pemberton M., Bradshaw M. Mediating mechanisms of a military web-based alcohol intervention. Drug and Alcohol Dependence 2009, 100:248-257. 10.1016/j.drugalcdep.2008.10.007.